Literature DB >> 26905437

Surface proteome analysis identifies platelet derived growth factor receptor-alpha as a critical mediator of transforming growth factor-beta-induced collagen secretion.

Katharina Heinzelmann1, Nina Noskovičová1, Juliane Merl-Pham2, Gerhard Preissler3, Hauke Winter3, Michael Lindner4, Rudolf Hatz5, Stefanie M Hauck2, Jürgen Behr6, Oliver Eickelberg7.   

Abstract

Fibroblasts are extracellular matrix-producing cells in the lung. Fibroblast activation by transforming growth factor-beta leads to myofibroblast-differentiation and increased extracellular matrix deposition, a hallmark of pulmonary fibrosis. While fibroblast function with respect to migration, invasion, and extracellular matrix deposition has been well-explored, little is known about the surface proteome of lung fibroblasts in general and its specific response to fibrogenic growth factors, in particular transforming growth factor-beta. We thus performed a cell-surface proteome analysis of primary human lung fibroblasts in presence/absence of transforming growth factor-beta, followed by characterization of our findings using FACS analysis, Western blot, and siRNA-mediated knockdown experiments. We identified 213 surface proteins significantly regulated by transforming growth factor-beta, platelet derived growth factor receptor-alpha being one of the top down-regulated proteins. Transforming growth factor beta-induced downregulation of platelet derived growth factor receptor-alpha induced upregulation of platelet derived growth factor receptor-beta expression and phosphorylation of Akt, a downstream target of platelet derived growth factor signaling. Importantly, collagen type V expression and secretion was strongly increased after forced knockdown of platelet derived growth factor receptor-alpha, an effect that was potentiated by transforming growth factor-beta. We therefore show previously underappreciated cross-talk of transforming growth factor-beta and platelet derived growth factor signaling in human lung fibroblasts, resulting in increased extracellular matrix deposition in a platelet derived growth factor receptor-alpha dependent manner. These findings are of particular importance for the treatment of lung fibrosis patients with high pulmonary transforming growth factor-beta activity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell signaling; Cell surface; Mass spectrometry; Pulmonary fibrosis; Surface proteome; fibroblasts

Mesh:

Substances:

Year:  2016        PMID: 26905437     DOI: 10.1016/j.biocel.2016.02.013

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.

Authors:  Xianchai Lin; Jiamin Wen; Rongjiao Liu; Wuyou Gao; Bo Qu; Minbin Yu
Journal:  Mol Vis       Date:  2018-12-09       Impact factor: 2.367

2.  Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop Report.

Authors:  Robert M Tighe; Elizabeth F Redente; Yen-Rei Yu; Susanne Herold; Anne I Sperling; Jeffrey L Curtis; Ryan Duggan; Suchitra Swaminathan; Hideki Nakano; William J Zacharias; William J Janssen; Christine M Freeman; Ryan R Brinkman; Benjamin D Singer; Claudia V Jakubzick; Alexander V Misharin
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

3.  Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis.

Authors:  Juliane Merl-Pham; Trayambak Basak; Larissa Knüppel; Deepak Ramanujam; Mark Athanason; Jürgen Behr; Stefan Engelhardt; Oliver Eickelberg; Stefanie M Hauck; Roberto Vanacore; Claudia A Staab-Weijnitz
Journal:  Matrix Biol Plus       Date:  2019-04-13

4.  Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease.

Authors:  Jose-Ramon Blanco; María-Jesús Cobos-Ceballos; Francisco Navarro; Isabel Sanjoaquin; Carlos Armiñanzas; Enrique Bernal; Luis Buzon-Martin; Miguel Viribay; Laura Pérez-Martínez; Simona Espejo-Pérez; Borja Valencia; Jesus Guzman-Aguilar; Juan-Jose Ruiz-Cubillan; Consuelo Alcalde; Fernando Gustavo Gutierrez-Herrero; Julian Olalla; Eva-Maria Andres-Esteban; Bernabe Jurado-Gamez; Javier Ugedo
Journal:  Aging (Albany NY)       Date:  2022-02-16       Impact factor: 5.682

5.  Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.

Authors:  Michael Gerckens; Kenji Schorpp; Francesco Pelizza; Melanie Wögrath; Kora Reichau; Huilong Ma; Armando-Marco Dworsky; Arunima Sengupta; Mircea Gabriel Stoleriu; Katharina Heinzelmann; Juliane Merl-Pham; Martin Irmler; Hani N Alsafadi; Eduard Trenkenschuh; Lenka Sarnova; Marketa Jirouskova; Wolfgang Frieß; Stefanie M Hauck; Johannes Beckers; Nikolaus Kneidinger; Jürgen Behr; Anne Hilgendorff; Kamyar Hadian; Michael Lindner; Melanie Königshoff; Oliver Eickelberg; Martin Gregor; Oliver Plettenburg; Ali Önder Yildirim; Gerald Burgstaller
Journal:  Sci Adv       Date:  2021-12-22       Impact factor: 14.957

6.  Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.

Authors:  Julien Solinc; Jessica Raimbault-Machado; France Dierick; Lamiaa El Bernoussi; Ly Tu; Raphaël Thuillet; Nathalie Mougenot; Bénédicte Hoareau-Coudert; Virginie Monceau; Catherine Pavoine; Fabrice Atassi; David Sassoon; Giovanna Marazzi; Richard P Harvey; Peter Schofield; Daniel Christ; Marc Humbert; Christophe Guignabert; Florent Soubrier; Sophie Nadaud
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

Review 7.  The BPD trio? Interaction of dysregulated PDGF, VEGF, and TGF signaling in neonatal chronic lung disease.

Authors:  Prajakta Oak; Anne Hilgendorff
Journal:  Mol Cell Pediatr       Date:  2017-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.